Annual report pursuant to Section 13 and 15(d)

Prepaid Expenses and Other Current Assets (Tables)

v3.22.1
Prepaid Expenses and Other Current Assets (Tables)
12 Months Ended
Dec. 31, 2021
Prepaid Expense And Other Assets Current [Abstract]  
Summary of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following:

 

 

December 31, 2021

 

 

December 31, 2020

 

Research and development tax credit receivable

 

$

840

 

 

$

801

 

Prepaid insurance

 

 

624

 

 

 

415

 

Interest receivable

 

 

290

 

 

 

 

Value added tax receivable

 

 

75

 

 

 

64

 

Other prepaid assets

 

 

56

 

 

 

231

 

Short-term deposits

 

 

37

 

 

 

2,360

 

Refundable FDA filing fee (1)

 

 

 

 

 

2,876

 

Prepaid research and development expenses

 

 

 

 

 

157

 

Total

 

$

1,922

 

 

$

6,904

 

(1) FDA filing fee refund of $2,876 was received in January 2021